Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Genetics of Alzheimer disease in the pre- and post-GWAS era 2010-03-05
  2. The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease 2008-01-01

Studies

2 studies carry this tag.

Date range

2008 to 2010

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Alzheimer's research & therapy 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Genetics of Alzheimer disease in the pre- and post-GWAS era

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Alzheimer's research & therapy 2010-03-05 Genetics

    Since the 1990s, the genetics of Alzheimer disease (AD) has been an active area of research.

  2. The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2008-01-01 Risk factors

    Studies of therapeutic agents in SCI treatment and resultant Alzheimer's disease prevention appear to be feasible.

All topic tags with their study counts